Processing of Apple Pomace for Bioactive Molecules

The growth of horticulture industries worldwide has generated huge quantities of fruit wastes (25%–40% of the total fruits processed). These residues are generally a good source of carbohydrates, especially cell wall polysaccharides and other functionally important bioactive molecules such as proteins, vitamins, minerals and natural antioxidants. “Apple pomace” is a left-over solid biomass with a high moisture content, obtained as a by-product during the processing of apple fruits for juice, cider or wine preparation. Owing to the high carbohydrate content, apple pomace is used as a substrate in a number of microbial processes for the production of organic acids, enzymes, single cell protein, ethanol, low alcoholic drinks and pigments. Recent research trends reveal that there is an increase in the utilization of apple pomace as a food processing residue for the extraction of value added products such as dietary fibre, protein, natural antioxidants, biopolymers, pigments and compounds with unique properties. However, the central dogma is still the stability, safety and economic feasibility of the process(s)/product(s) developed. This review is mainly focused on assessing recent research developments in extraction, isolation and characterization of bioactive molecules from apple pomace, along with their commercial utilization, in food fortification.     

驴源兽疫链球菌的分离鉴定及多位点序列分型分析

【目的】本研究采集了新疆地区驴腺疫病料,从样品中分离鉴定可疑病原菌并对其进行基因水平的分型与进化分析。【方法】对采集的新疆地区某驴场驴腺疫病驴颌下淋巴结拭子进行细菌分离培养,对2个分离株(HT111、HT321)进行染色、培养、生化试验、药敏试验,对其16S rRNA及SeM基因进行测序和进化分析,并通过PCR扩增7个管家基因,利用多位点序列分型(MLST)方法鉴定其分子分型。【结果】2个分离株均属马链球菌兽疫亚种,其中HT111对测试的13种抗生素中的3种(青霉素、克拉霉素和四环素)耐药,HT321对8种抗生素(阿莫西林、头孢呋辛、头孢噻呋、青霉素、克拉霉素、克林霉素、土霉素和四环素)耐药。序列分型发现了一种新的ST型为ST420 (HT321),分离株HT111为ST179型。【结论】本研究在新疆地区首次分离了驴源马链球菌兽疫亚种,并鉴定出一个新的ST型(ST420),为驴腺疫的流行病学提供了参考数据。     

Modulating the Adhesion of Haematopoietic Stem Cells with Chemokines to Enhance Their Recruitment to the Ischaemically Injured Murine Kidney

Introduction

Renal disease affects over 500 million people worldwide and is set to increase as treatment options are predominately supportive. Evidence suggests that exogenous haematopoietic stem cells (HSCs) can be of benefit but due to the rarity and poor homing of these cells, benefits are either minor or transitory. Mechanisms governing HSC recruitment to injured renal microcirculation are poorly understood; therefore this study determined (i) the adhesion molecules responsible for HSC recruitment to the injured kidney, (ii) if cytokine HSC pre-treatment can enhance their homing and (iii) the molecular mechanisms accountable for any enhancement.

Methods

Adherent and free-flowing HSCs were determined in an intravital murine model of renal ischaemia-reperfusion injury. Some HSCs and animals were pre-treated prior to HSC infusion with function blocking antibodies, hyaluronidase or cytokines. Changes in surface expression and clustering of HSC adhesion molecules were determined using flow cytometry and confocal microscopy. HSC adhesion to endothelial counter-ligands (VCAM-1, hyaluronan) was determined using static adhesion assays in vitro.

Results

CD49d, CD44, VCAM-1 and hyaluronan governed HSC adhesion to the IR-injured kidney. Both KC and SDF-1α pre-treatment strategies significantly increased HSC adhesion within injured kidney, whilst SDF-1α also increased numbers continuing to circulate. SDF-1α and KC did not increase CD49d or CD44 expression but increased HSC adhesion to VCAM-1 and hyaluronan respectively. SDF-1α increased CD49d surface clustering, as well as HSC deformability.

Conclusion

Increasing HSC adhesive capacity for its endothelial counter-ligands, potentially through surface clustering, may explain their enhanced renal retention in vivo. Furthermore, increasing HSC deformability through SDF-1α treatment could explain the prolonged systemic circulation; the HSC can therefore continue to survey the damaged tissue instead of becoming entrapped within non-injured sites. Therefore manipulating these mechanisms of HSC recruitment outlined may improve the clinical outcome of cellular therapies for kidney disease.     

膝部骨折合并腘动脉损伤23例临床分析

目的：回顾性分析膝部骨折合并腘动脉损伤的治疗方法和效果。方法：23例膝部骨折合并腘动脉损伤的患者,其中肢体严重缺血患者（远端动脉搏动消失,皮温下降,皮肤花斑或者苍白）13例,部分缺血患者（远端动脉搏动减弱,或者消失但有毛细血管充盈征）10例。腘动脉修复方法：端端吻合术4例,修补术5例,切开取栓术3例,对侧大隐静脉移植修复术10例。修复顺序：先修复血管再固定骨折8例,先固定骨折再修复血管14例,处理骨折前先建立临时性动脉内分流10例。结果：肢体存活19例,截肢4例。截肢者均为严重缺血患者,其中1例患者因严重骨折和广泛软组织损伤合并急性肾功能衰竭行I期截肢,3例患者因术后反复感染（1例合并肾功能不全）行Ⅱ期截肢。严重缺血的患者只有3/13例完全恢复,而部分缺血的患者有6/10例完全恢复。血管再通时间≥8h的患者只有4/13例完全恢复,而血管再通时间〈8h的患者有5/9完全恢复。结论：膝部骨折合并腘动脉损伤时,肢体缺血程度和缺血时间是影响患者康复的重要因素,术后感染仍是造成截肢的主要原因。     

腐植酸生产菌株——链霉菌发酵条件研究

利用链霉菌ST菌株发酵生产腐植酸。在蔗渣发酵培养基的基础上,采用一次回归正交试验,对腐植酸发酵过程中接种量（I）、通气量（搅拌次数,A）、温度（T）及时间（D）4个因素对腐植酸产量的影响情况进行分析。结果表明发酵时间的影响最为显著,接种量影响显著;所得到的回归方程有效且可信度高,回归方程为Y=6．0356＋0．02501＋0．0033A＋0．0069T＋0．2425D,其中各因素均与腐植酸产量呈正相关性。该回归方程为腐植酸生产过程链霉菌ST菌株发酵条件的控制提供了很好的指导作用。     

人干扰素ω(huIFN-ω)的高效表达、纯化及生物学活性

为了获得人干扰素-ω(huIFN-ω)在大肠杆菌中的高效表达,根据大肠杆菌的偏爱密码子,人工设计并合成了huIFN-ω高表达基因,并克隆到原核表达载体pBV220,在大肠杆菌DH5α中实现了高效表达,目的蛋白占细胞总蛋白的15%左右,以包涵体形式存在.表达产物经变性、复性及阳离子和分子筛层析纯化,纯度达90%以上,产物的抗病毒活性约为1.0×108IU/mg,并具有体外促NK杀伤活性.此结果为进一步研究和开发重组huIFN-ω奠定了基础.     

口蹄疫O/China/99毒株在不同宿主系传代的3A和VP1基因变异研究

利用RT-PCR法扩增了经不同宿主系(乳鼠、BHK21细胞、PK15细胞)连传不同代次的口蹄疫O/China/99毒株的3A和VP1基因,并进行了核苷酸和氨基酸序列分析.结果表明,该毒株经不同宿主系传至90代后,VP1基因未发生大的变异,主要抗原位点也较稳定;而非结构蛋白3A基因却在不同宿主和代次发生突变缺失;经BHK21细胞传代后未发生缺失;经PK15细胞传代,在70～90代之间在第254～313位出现缺失;经乳鼠传代,在60～70代之间在第265～300位发生缺失,并在以后的90代毒中仍在此位缺失.这与代表性猪源流行毒O/YUN/TAW/97和O/HKN/21/70的3A基因在第276～305位发生缺失有相同之处.     

可发酵糖为底物不同菌种丁醇生产能力的研究

随着新一代生物质能源的研发,利用梭菌的发酵生产丁醇已成为热点。选用能生产丁醇的Clostridium acetobutylicum AS1.7,Clostridium acetobutylicum AS1.132,Clostridium acetobutylicumAS1.134和Clostridium beijerinckii NCMIB 8052,在多种糖源下进行发酵培养,通过比较其在不同糖源条件下的生长情况、糖利用率、丁醇及副产物产量、对丁醇、木糖耐受能力等,综合筛选出了最适用于发酵生产丁醇的备选菌种。NCMIB8052因具有最高产量、相对优良的耐受性及可利用多种糖源的特点,而被确定为发酵能力最强的菌种。     

前入路腹膜前修补腹股沟疝82 例临床分析

目的:探讨Modified Kugel补片治疗腹股沟疝的手术操作要点,并评价其疗效。方法:对2010年1~12月我院应用ModifiedKugel补片行开放性前入路腹膜前修补术的82例临床资料进行回顾性分析。结果:平均手术时间(55±10)min,术后住院(5.2±1.4)d。术后无尿潴留、切口感染等并发症。全组病人伤口一期愈合,无浆液肿及感染发生。术后随访12-23个月,无复发。结论:应用Modified Kugel补片修补腹股沟疝是一种创伤小、无张力、安全的手术方式,术后恢复快,近期疗效满意。     

基于SVM 的药物靶点预测方法及其应用

目的:基于已知药物靶点和潜在药物靶点蛋白的一级结构相似性,结合SVM技术研究新的有效的药物靶点预测方法。方法:构造训练样本集,提取蛋白质序列的一级结构特征,进行数据预处理,选择最优核函数,优化参数并进行特征选择,训练最优预测模型,检验模型的预测效果。以G蛋白偶联受体家族的蛋白质为预测集,应用建立的最优分类模型对其进行潜在药物靶点挖掘。结果:基于SVM所建立的最优分类模型预测的平均准确率为81.03%。应用最优分类器对构造的G蛋白预测集进行预测,结果发现预测排位在前20的蛋白质中有多个与疾病相关。特别的,其中有两个G蛋白在治疗靶点数据库(TTD)中显示已作为临床试验的药物靶点。结论:基于SVM和蛋白质序列特征的药物靶点预测方法是有效的,应用该方法预测出的潜在药物靶点能够为发现新的药靶提供参考。